| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $488K | +26.4% |
| R&D Expense | $32.9M | +21.2% |
| SG&A Expense | $13.0M | -1.0% |
| Operating Income | -$45.4M | -13.8% |
| Income Tax | $0 | — |
| Net Income | -$41.4M | -7.1% |
| EPS (Basic) | -$0.93 | -4.5% |
| EPS (Diluted) | -$0.93 | -4.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.7M | +32.5% |
| Short-term Investments | $53.2M | -40.2% |
| Accounts Receivable | $288K | -62.6% |
| Current Assets | $77.4M | -30.4% |
| Total Assets | $81.6M | -29.7% |
| Current Liabilities | $10.4M | +33.7% |
| Total Liabilities | $11.9M | +20.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.9M | +8.7% |
| Capital Expenditures | $582K | -42.1% |
| Investing Cash Flow | $36.2M | -5.1% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$31.5M | +9.6% |
| Stockholders' Equity |
| $69.7M |
| -34.4% |